3
Announcements
Trials
Browse
Landscape
Status
Completed
58
Recruiting
14
Terminated
11
Unknown
6
Withdrawn
4
Active not recruiting
4
Suspended
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
2
Thoracic
1
Head & Neck
1
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
28
Pancreatic Neoplasms
17
Stomach Neoplasms
13
Carcinoma, Hepatocellular
13
Breast Neoplasms
9
Rectal Neoplasms
7
Neoplasms
7
Esophageal Neoplasms
7
Colonic Neoplasms
7
Prostatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Endometrial Neoplasms
3
Diabetes Mellitus
3
Crohn Disease
3
Cholangiocarcinoma
3
Carcinoma, Renal Cell
3
Bile Duct Neoplasms
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Sarcoma
2
Peritoneal Neoplasms
2
Multiple Sclerosis
2
Multiple Myeloma
2
Melanoma
2
Liver Neoplasms
2
Irritable Bowel Syndrome
2
Head and Neck Neoplasms
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Carcinoma, Ovarian Epithelial
×
Gastrointestinal
×
Clear all
NCT03253575
2019-04-08
ANCERS-2
Mitra RxDx, Inc.
Suspended
800 enrolled